- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: mTOR inhibitor Selective estrogen receptor modulator
Total 2482 results
-
Shiraz University of Medical SciencesCompletedPregnancyIran, Islamic Republic of
-
Fengxi SuUnknownBreast Cancer Patients in Premenopausal | Estrogen and/or Progesterone Receptor PositiveChina
-
Institute of Cancer Research, United KingdomCompletedRaloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerBreast CancerUnited Kingdom
-
Rabin Medical CenterCompletedHereditary Hemorrhagic TelangiectasiaIsrael
-
AGO Study GroupCompletedOvarian Cancer | Peritoneal Cancer | Cancer of the Fallopian TubeGermany
-
Stanford UniversityUnited States Department of DefenseRecruitingBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited States
-
University Hospital, GasthuisbergCompleted
-
Peking Union Medical College HospitalNot yet recruitingBreast Cancer | Chemotherapy Induced Amenorrhea | Ovarian Function SuppressionChina
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital TuebingenNot yet recruitingMenopause | Breast Cancer Female | Healthy Female | Anti-estrogenic TherapyGermany
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompleted
-
Peking Union Medical College HospitalUnknownFemale Breast CancerChina
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Eli Lilly and CompanyRecruitingBreast NeoplasmsChina, Japan, United States, Australia, Taiwan, Belgium, Canada, United Kingdom, Spain, France, Argentina, Ireland, Netherlands, Turkey, Czechia, Korea, Republic of, Finland, Hungary, Italy, Mexico, Brazil, Germany, India, Austria, Greece, Roman... and more
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Medical College of WisconsinActive, not recruitingBreast Cancer | Invasive Breast CancerUnited States
-
University Hospitals Cleveland Medical CenterWithdrawn
-
ETOP IBCSG Partners FoundationUNICANCER; Danish Breast Cancer Cooperative GroupCompletedBreast CancerFrance, Denmark, Switzerland
-
Midwest Fertility SpecialistsCompleted
-
Institut Claudius RegaudCompleted
-
Sun Yat-sen UniversityUnknown
-
Satakunta Central HospitalTampere University; Tampere University HospitalCompleted
-
Massachusetts General HospitalActive, not recruitingOsteoporosis | Osteoporosis, PostmenopausalUnited States
-
ShionogiQuatRx PharmaceuticalsCompleted
-
Stanley Medical Research InstituteCompleted
-
European Institute of OncologyCompleted
-
University Magna GraeciaWithdrawn
-
Federal University of São PauloCompletedHypogonadotropic Hypogonadism | ProlactinomaBrazil
-
University of ParmaUnknown
-
Cedars-Sinai Medical CenterUnknown
-
Andrea DeCensiHerbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaboratorsNot yet recruiting
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Poland, Portugal, United Kingdom, France, Canada, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Brazil, Colombia, Greece, Taiwan, Malaysia, Philippines, Austria, R... and more
-
PfizerCompleted
-
Institut Claudius RegaudPHARMACIA SASCompleted
-
National Taiwan University HospitalMackay Memorial Hospital; Kaohsiung Medical University; Tri-Service General Hospital and other collaboratorsRecruitingBreast Ductal Carcinoma in SituTaiwan
-
Hospices Civils de LyonNot yet recruitingAzoospermia, NonobstructiveFrance
-
Eli Lilly and CompanyActive, not recruitingMetastatic Breast CancerSpain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
-
BHR Pharma, LLCTerminatedMammographic Breast DensityUnited States, Germany, Spain
-
Bagcilar Training and Research HospitalCompletedUnexplained Infertility | Ovulation DisorderTurkey
-
Baylor College of MedicineNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Universitair Ziekenhuis BrusselCompleted
-
Advocate Lutheran General HospitalCompleted
-
National Cancer Center, JapanPfizer; Korean Cancer Study GroupActive, not recruitingBreast NeoplasmsKorea, Republic of, Singapore, Japan, Taiwan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
MedSIRRecruitingBreast Cancer | Breast Cancer, Early-OnsetSpain, France